Field-tested thinking on how to scale big deal success.

Buyers evaluating deal execution software are usually comparing five different categories of product against each other without realizing it. Sorting them out first makes the shortlist obvious.

Most business case tools are built to produce a number. The number is not the hard part. Producing something a finance function will accept, on every deal rather than the ten largest, is the hard part.

A digital sales room fixes a real problem: the buyer has your material scattered across fourteen email attachments and you cannot see what anyone read. It is worth being clear that this is a distribution problem, and that distribution was probably not why your last complex deal stalled.

Most strategic account management software is really account planning software: a better container for an annual exercise. Whether that is what you need depends on why your accounts are underperforming.

Almost every account planning tool is evaluated on how good a plan it produces. Almost every account plan fails for a different reason: it stops being true, and nobody notices.

Most mutual action plans are abandoned by week three. The software rarely causes that, and rarely fixes it either, but some approaches survive contact with a real buying process better than others.

Most MEDDICC software makes it easier to record a qualification score. Whether that changes any outcome depends on what you believe the score is for.

Every sales organization has a methodology and a CRM. Far fewer have a way of reliably doing the work each deal requires. That gap is what deal execution names.

Sales enablement makes your sellers better at selling. Buyer enablement makes your buyers better at buying, which sounds like a slogan until you look at what buyers are actually struggling with.

Your CRM knows the stage, the amount, and the close date of every deal you have. It knows nothing about whether the work required to win them has been done.

MEDDICC tells you whether you have a deal. Miller Heiman's Blue Sheet tells you how to win it. After a career spent running complex enterprise deals, I still think the older framework is the better one, and I want to explain exactly why.

MEDDICC tells you whether you should believe your own deal. It was never designed to help your champion walk into a finance review and come out with money. Those are different jobs, and conflating them is why well-qualified deals still stall in approval.

Almost every enterprise sales team says it sells on value. Far fewer can produce, on a given open deal, a quantified case a CFO would accept. That gap is what the term is supposed to describe.

Your real competitor in most enterprise deals is not the other vendor on the shortlist. It is the decision to do nothing for another year, and ROI is a weak argument against it.

Account planning has a start date and an end date. Strategic accounts do not. That mismatch is the whole argument.

Most white space analysis produces a grid of products you have not sold to business units you have not reached. That is the easy half, and it is rarely where the growth is.

Ranking accounts by current revenue tells you who you have already sold to. It is the most common tiering method and the least informative one.

Most sales AI observes the deal. Agentic deal execution does the work the deal requires. The distinction matters more than the label, and it is the difference between a tool that tells you what went wrong and a system that makes sure less goes wrong.